期刊
JOURNAL OF IMMUNOLOGY
卷 182, 期 1, 页码 274-282出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.182.1.274
关键词
-
类别
资金
- Medical Research Council Career Development Fellowship
- Biotechnology and Biological Sciences Research Council/Astrazeneca Case Studentship
- University of Birmingham Scientific Projects Committee
- BBSRC [BB/D011000/1] Funding Source: UKRI
- MRC [G120/854] Funding Source: UKRI
- Medical Research Council [G9818340B, G120/854] Funding Source: researchfish
The CTLA-4 pathway is recognized as a major immune inhibitory axis and is a key therapeutic target for augmenting antitumor immunity or curbing autoimmunity. CTLA-4-deficient mice provide the archetypal example of dysregulated immune homeostasis, developing lethal lymphoproliferation with multiorgan inflammation. In this study, we show that surprisingly these mice have an enlarged population of Foxp3(+) regulatory T cells (Treg). The increase in Treg is associated with normal thymic output but enhanced proliferation of Foxp3(+) cells in the periphery. We confirmed the effect of CTLA-4 deficiency on the Treg population using OVA-specific Treg which develop normally in the absence of CTLA-4, but show increased proliferation in response to peripheral self-Ag. Functional analysis revealed that Ag-specific Treg lacking CTLA-4 were unable to regulate disease in an adoptive transfer model of diabetes. Collectively, these data suggest that the proliferation of Treg in the periphery is tuned by CTLA-4 signals and that Treg expression of CTLA-4 is required for regulation of pancreas autoimmunity. The Journal of Immunology, 2009, 182: 274-282.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据